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EXECUTIVE SUMMARY 
This Honors Project focuses on furthering the study of using predictive mathematical models to 
determine if one amino acid can be substituted for another. Substitution of amino acids allows 
drugs to be developed using amino acids as substitutes for the targeted amino acid. A method to 
predict the success of this substitution mathematically would allow drugs to be developed faster 
and have a greater success rate when then used in human trials. This Honors Project focused on 
three aspects of this topic: 
 Duplicating the work of Jean-Loup Faulon who used the molecular signature to 
investigate drug effectiveness 
 Comparing the molecular signature kernels to three of the BLOSUM matrices (30, 62, 
and 90) to test the accuracy of the mathematical model 
 Manipulating the kernel matrix in order to improve the relationship:  
o 1. Focusing on side groups  
o 2. Changing how the structure was represented in the matrix by increasing the 
initial height distance from the central atom (Height 1 and Height 2 included) 
The molecular signature is a method that describes a chemical or biological structure by counting 
individual structure groups based on distances from a certain atom. The quantifiable approach is 
used to describe chemicals and will now be used to describe amino acids and proteins. If the 
approach is proven to be reliable, the molecular signature could be used to predict whether a 
drug will be effective inside a patient due to similarities found between the drug and the target 
protein. There were multiple design constraints for this project. The first was the comparison 
with the BLOSUM matrices (30,62, and 90) which characterized the substitution ability of each 
pair of amino acids as found in nature. The next constraint was the use of the molecular signature 
as a way to describe the structure of the amino acids.   The last constraint was the usage of the 
signature kernel equation which was used in order to repeat a previous study by Jean-Loup 
Faulon.   
The Honors Project first starts by calculating the kernel values  with the molecular signature 
values for the original matrix (without any modification) and resulted in a linear  correlation R2 
value with BLOSUM62 of 0.83. In order to improve the linear relationship, it was predicted that 
the side groups  for the amino acids were the most important aspect of the structure. In order to 
investigate that, the matrix was modified to take out the signature values that described the 
“backbone” of the amino acid and focused on the side groups. The linear relationship of the 
BLOSUM62 and the kernel values of the modified matrix did improve with a higher linear 
correlation R2 value  of 0.87. Other results included trends in regards to the amino acid and the 
BLOSUM matrix values. According to this investigation, the amino acids with large nonpolar or 
large aromatic side groups resulted in the lowest BLOSUM scores. For example, Tryptophan, 
Arginine, and Phenylalanine were among the amino acids with the lowest BLOSUM scores.. 
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Further investigation with regards to atom height, was attempted in order to improve the linear 
relationship more. The next experiment tested a matrix with a height of 2 with molecular 
signature. The linear relationship of the BLOSUM62 and the kernel values of the height 2 matrix 
did improve even more and resulted as 0.93. According to this investigation, the improved 
relationship will occur when there is a larger height with an all-atom approach. 
As a result, it can be concluded that improvement of the molecular signature kernel matrix 
should not rely on one aspect of the amino acid. The prediction of similarity as seen in nature 
relies on many complicated factors but polarity should not be discounted as one of them.  From 
observations of the results, it is apparent that polarity does make a difference in nature and using 
height 1 or a two-dimensional method will limit the results. Other important properties could be 
bulkiness of the side group, three-dimensional structure, and the orientation of amino acid. As 
the height of the molecular signature increases, the three-dimensional structure and orientation of 
the amino acid will be represented as shown by the higher linear relationship. 
There are many important implications of this investigation. The following is a list of skills 
obtained from the project: increased knowledge of the bioinformatics field and knowledge of 
ways to evaluate mathematical similarity methods, a better understanding of structures of amino 
acids and how the properties of proteins directly correlate to those building blocks, and finally 
more proficient programming skills and understanding of the direct application of C++ in order 
to solve a big data problem. The project improved self confidence in the subject matter and it 
gave the opportunity to work on a project with the help of a senior advisor. Molecular signature 
descriptors could prove to be a reliable way to quantify the relationship between amino acids 
within proteins. If this became a reliable method it could be an affordable way to predict protein 
–protein interaction and give an early start to investigate drug options for patients. Safer drug use 
will result in less people dying every year from drug use complications. Also, a future benefit 
could be the identification of dangerous drug to drug interactions thus helping save lives from 
unknown negative drug interactions. 
Moving forward, future investigations should account for height 3 or higher and investigate 
different trends that mimic the trends found within the BLOSUM62 matrix. If further patterns 
are found within the BLOSUM62 matrix then those could be used to modify future matrices and 
find an even higher linear correlation than was found in this investigation. It is also 
recommended to keep in mind that multiple factors (different pH levels and intermolecular 
forces) occur at once and individual investigations may overlook the synergistic effect on the 
structure of the amino acid as seen in nature. 
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BACKGROUND: 
The research and investigation of this Honor’s project primarily revolved around a paper from 
Jean-Loup Faulon et al called Genome scale enzyme-metabolite and drug-target interaction 
predictions using the signature molecular descriptor1. Faulon’s research focuses on possible 
bioinformatics application of the molecular signature. The molecular signature is used to 
describe chemicals but further application includes describing amino acids and proteins. Faulon’s 
investigation tries to use the molecule signature to predict similarities between a drug and its 
target protein. The implication for the future is to use this method to predict if a drug would be 
effective for the patient prior to the patient ingesting the drug.  In a section of Faulon’s research, 
he investigates the relationship between pairs of amino acids calculated by the molecular 
signature and the values of the substitution BLOSUM62 matrix. This relationship is important 
since it is used to evaluate the effectiveness of the molecular signature approach.   
The BLOSUM 62 matrix numerical values are determined by two strands of DNA that are 62% 
similar in sequence alignment. The matrix values represent how likely two amino acids can be 
substituted for each other. If the BLOSUM62 matrix element for a certain pair has a large 
positive value then it occurs more frequently in nature and is less likely to impact protein 
function. For example, Valine and Isoleucine pairing have a BLOSUM62 score of 3. Proline and 
Proline have a score of 7 since their structure is the same.  Some pairs of amino acids can have 
values as low as -4 or -3 which means these substitutions would rarely occur in nature and if they 
did occur would likely result in an important change in protein function. For example, Valine 
and Tryptophan have a score of -4, which is due to a difference in structure since Valine has a 
nonpolar side group while Tryptophan has an aromatic side group. 
The molecular signature is an all atom approach used to quantify the relationship between two 
chemical structures or, in this case, amino acids. The atomic signature is a basic method for 
identifying an amino acid. Due to the growing databases being used for the identification of 
different proteins and chemicals, there is a need to find a highly reliable computational method 
for categorizing chemical structures. Non-computational methods include high throughput 
screening and virtual screening. High throughput screening uses known groups of compounds 
and compares their structure to the unknown structure in order to identify the unknown. Virtual 
Screening utilizes homology similarities in order to identify the unknown compound. When 
identifying proteins with virtual screening, ligand structure is highly important.2 The 
computational method is a better approach since it is faster and more accurate and the other 
approaches involves experimentation.  
There are also other approaches that build upon the molecular signature in order to describe 
properties. One example is QSPR that is used to describe the properties of different polymers.3 In 
order to expand upon the molecular signature approach; it needs to be proven reliable at its basic 
level, meaning usage at Height 1 or Height 2. The molecular signature descriptor is a method that 
is public and free to use around the world. There is a strong motivation to improve this approach 
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in order to expand upon the predictability of molecular structures. The implication is to use this 
approach to predict the usefulness of a drug by comparing the drug protein and the target protein 
expressed by the patient’s genome. The individualized approach could advance personalized 
medicine and potentially save millions of lives.  
In Faulon’s research, he investigates the molecular signature and how it is used to quantify the 
similarity between two amino acids. The molecular signature of a molecule is comprised of 
atomic signatures that are denoted by the amount of atoms which are a predefined distance from 
a central atom. The predefined distance is called the signature height that is characterized by a 
vector. In this Honor’s project first investigation, the height distance was 1 which was later 
increased to a height of 2. In Faulon’s research, he used a height of 1 as well. If G is a function 
of V (vertex atom) and E (signature height), then Equation 1 shows the equation for the 
molecular signature: 
 
Equation 1. hσG(x) is the unit base vector that is the atomic signature G embedded at x with a 
height h.1 
For example, Figure 1 shows the molecular signature for the matrix row of Alanine. The 
structure of the amino acid is shown next to it. The signatures are generated by focusing on 
atoms right next to each other. This process is utilizing a height of 1. The different atom 
combinations are counted and used in the matrix row. 
 
Figure 1. The molecular signature matrix row for Alanine.4 
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While signatures are vectors, Faulon’s research also included calculations of signature kernels 
where the results are scalar values. The signature kernel represents a relationship between two 
amino acids with the values ranging from 0 to 1. A kernel value that is closer to one means that 
the structures are more closely related. The kernel is calculated by taking the dot product of the 
molecular signatures in the numerator. The denominator is for normalization and is found by 
squaring each value in the vector and summing them, and then taking the square root. An 
example of a calculation of the kernel is found in Appendix D. Equation 2 shows the equation for 
calculating the signature kernel. 
hk(A,B) = 
σℎ (𝐴)∙ σℎ (𝐵)
| σℎ (𝐴)|| σℎ (𝐵)|
    (2) 
Equation 2. Kernel function with the denominator as the vector norm. 
where hσ(𝐴) and hσ(𝐵) are the molecular signatures from Equation 1 and |σ(𝐴)| represents the 
norm of hσ(𝐴). 
Faulon’s research included a figure that showed the correlation between the calculated values for 
the signature kernel of pairs of amino acids and the BLOSUM62 value. 
 
 Figure 2. The signature kernel vs the BLOSUM62 score. Standard deviation values were 
included.1 
Figure 2 shows  a strong correlation between the signature similarity and the BLOSUM62 score. 
 
 
 
7 
 
PURPOSE: 
The purpose of this Honors Project is three-fold. To replicate Faulon’s research and compare 
results with more than one BLOSUM matrix. To investigate how concentrating on the structure 
of the side chain of each amino acid affects the results with the three BLOSUM matrices (30,62, 
and 90). The signature kernel matrix will be manipulated to only include the structure of the 
“side chain”. Also, the kernel matrix will also be changed to increase the height distance from a 
central atom to include height 2 . The last two changes will involve manipulation of the signature 
kernel matrix. It was predicted to improve the linear relationship when compared to the 
BLOSUM62 matrix. The results were then compared in order to determine if there is a higher 
correlation focusing on an all-atom approach (Height 1 and Height 2) or focusing on the 
structure of the side chain with the BLOSUM matrices. 
METHODS: 
A program was written in C++ in order to calculate the signature kernel. The molecular signature 
was input as an array with 20 rows (20 amino acids) and 34 columns describing their structure. It 
was calculated using 2d mol files from the NIST WebBook of each amino acid. The molecular 
signature for each amino acid can be found in Appendix B while the actual matrix is found in 
Appendix C. Each row was fed in and multiplied by each other using the kernel equation 
(Equation 2) from the Background section. An example of that calculation is found in Appendix 
D. The kernel output was also an array that was analyzed using an Excel spreadsheet. Appendix 
A shows the code used by the IDE compiler CodeBlocks. 
RESULTS: 
The signature kernel followed a fairly similar pattern with the BLOSUM matrices. In Figure 3, 
the BLOSUM matrices 30, 62, and 90 and their respective kernel signatures were compared 
against each other. BLOSUM62 matrix and the signature kernel had the highest linear correlation 
value (R2 value was 83%) followed by BLOSUM90. 
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Figure 3 shows how there are patterns associated with the BLOSUM matrices and the signature 
similarity. There is a general positive correlation between the signature value and the BLOSUM 
score. The R2 linear correlation value was 83%.  
 
Figure 3. Signature similarity as seen in Faulon’s research with standard deviation ranges. 
Further exploration investigated the relationship of the BLOSUM score and the individual amino 
acids. The purpose of the further investigation is to find patterns between BLOSUM62 scores 
and amino acids. These patterns will help find possible ways of improving the signature kernel 
matrix. Some amino acids averaged lower scores than others due to their difference in structure. 
BLOSUM62 appeared to be the most accurate correlating a linear relationship between the 
BLOSUM score and the signature kernel value and so it was the main focus of the three 
BLOSUM matrices. Table 1 shows that the individual size of the amino acid influences the 
associated BLOSUM score.  The number of times an amino acid had a certain range of 
BLOSUM scores were counted to compare the amino acids individually. Each amino acid has a 
total of 19 values across Table 1 since it can be paired up with all of the others. This table shows 
how each amino acid varies with the other. For instance, Tryptophan and Phenylalanine are very 
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large amino acids with benzene rings in their structure. These amino acids are largely associated 
with negative BLOSUM scores. Interestingly, Isoleucine is also associated with a large negative 
BLOSUM score as well. Isoleucine is an amino acid that is nonpolar that could cause 
disturbances when substituted for amino acid with different properties. The observations from 
Table 1 show that structure alone cannot predict the substitution ability of an amino acid and that 
polarity is also a factor. 
Table 1. Individual Amino Acids with associated BLOSUM62 matrix score. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 shows evidence that the entire structure of the amino acid should not be the only tool to 
predict the substitution ability. Figure 4 shows a graph where the only inconsistent parts of the 
kernel signature values were the end points (0.65 and 0.950-0.999). A lack of linear relationship 
can be seen at both ends of the figure. If the specific polarity is accounted for on the side chains, 
then the prediction of the signature kernel would be more accurate. In order to help interpret the 
data in Figure 4 and Table 1, Appendix B shows the structure of each amino acid and the 
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classification group it belongs to based on its side group structure. Appendix B also shows the 
molecular signature of each of the structure of the amino acid.   
 
Figure 4. Line graph showing the association between the average BLOSUM scores of the three 
BLOSUM matrices and the kernel signature values.  
 
FURTHER RESEARCH: Improved Molecular Signature  
The signature kernel used in the investigation quantifies the molecule in an all atom approach 
which means that every part of the atom counts equally to calculate the signature kernel value. If 
polarity is a factor in terms of substitution ability, the atoms in the side chain should have a 
higher influence on the signature kernel values. A modified version of the molecular signature 
matrix was used in the next analysis in order to obtain a more precise relationship between the 
molecular signature and the BLOSUM matrices. The modified matrix values can be found in 
Appendix C. Figure 5 shows the new relationship of the BLOSUM matrices and the modified 
matrix molecular signature kernel. Between Figure 3 and Figure 5, there is an improvement in 
the R2 values. The R2 values increase from 0.83 to 0.87 thus showing a higher correlation. 
Additional investigation was done in order to calculate the molecular signature kernel values at 
height 2. It was hypothesized that this change would result in even better accuracy or a higher 
linear relationship with the BLOSUM 62 matrix. This is because at  height 2, the perimeter or 
outside atoms are more represented in the kernel values which better mimics the structure of the 
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amino acids in nature. As the height values increase, so does the representation of the three-
dimensional space of the amino acid.  A higher height difference should improve the linear 
correlation R2 value.    
 
Figure 5. Signature similarity with the modified matrix for Molecular Signature. 
Also, in addition, an investigation of molecular signature at height 2 was calculated and 
compared to the original matrix. Figure 6 shows the results from the investigation. As expected, 
the linear relationship improved increasing from 0.83 in Figure 3 to 0.93 in Figure 6.  
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Figure 6. Signature similarity with the Height 2 matrix for Molecular Signature. 
Figure 7 shows the final result of the modified signature matrix kernel calculations using the 
BLOSUM matrices 90, 62, and 30. The trends associated with this figure shows that there is an 
improvement with the correlations from Figure 4 to Figure 7. In Figure 4, the middle of the 
graph had a higher correlation than the ends of the graph that showed a slight dip in the data. In 
Figure 7, the ends of the graph included less “dips” in data while the middle of the graph tended 
to oscillate more than in Figure 4. 
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Figure 7. Line graph showing the association between the average BLOSUM scores of the three 
BLOSUM matrices and the modified matrix kernel signature values. 
 
Figure 8. Line graph showing the association between the average BLOSUM scores of the three 
BLOSUM matrices and the height 2 matrix kernel signature values. 
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Figure 8 shows the final result of the height 2 signature matrix kernel calculations using the 
BLOSUM matrices 90, 62, and 30. The trends associated with this figure shows that there is an 
improvement with the correlations from Figure 4 to Figure 8. In Figure 4, the middle of the 
graph had a higher correlation than the ends of the graph that showed a slight dip in the data. In 
Figure 8, the only “dip” was on the left end of the graph with the lower kernel values while the 
middle of the graph towards the right end showed an increased linear trend with consistent slopes 
across all BLOSUM matrices. 
 
DISCUSSION: 
There were multiple design constraints for this project:  
1. Comparison with the BLOSUM matrices (30, 62, and 90) which characterized the substitution 
ability of each pair of amino acids as found in nature.  
2. Use of the molecular signature as a way to describe the structure of the amino acids. Since the 
molecule signature descriptor is a public resource, no funds were needed for this project.  
3. The signature kernel equation that was used in order to repeat a previous study by Jean-Loup 
Faulon.      
Through all three aspects of this Honors Project, it can be inferred that the molecular signature 
relies on both the polarity and the core backbone of the structure of the amino acid. Throughout 
the study, the linear relationship improved with each experiment which shows the importance of 
the height of the molecular signature and polarity of the side groups. 
When analyzing the data, the trend of side groups did account for fluctuations in the data. In 
Table 1, some of the large and nonpolar amino acids had the lowest BLOSUM scores. This 
indicates polarity and size of the side group matters with regards to the substitution ability of 
amino acids for each other. 
In each of the investigations, multiple BLOSUM matrices were used in order to prove 
consistency. According to Faulon, BLOSUM62 is the most used matrix since it is most 
consistently seen in nature.1  
 
CONCLUSION:     
This Honors Project focuses on furthering the study of using predictive mathematical models to 
determine if one amino acid can be substituted for another. Substitution of amino acids allows 
drugs to be developed using amino acids as substitutes for the targeted amino acid. A method to 
predict the success of this substitution mathematically would allow drugs to be developed faster 
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and have a greater success rate when then used in human trials. This Honors Project focused on 
three aspects of this topic: 
 Duplicating the work of Jean-Loup Faulon who used the molecular signature to 
investigate drug effectiveness 
 Comparing the molecular signature kernels to three of the BLOSUM matrices (30, 62, 
and 90) to test the accuracy of the mathematical model 
 Manipulating the kernel matrix in order to improve the relationship:  
o 1. Focusing on side groups  
o 2. Changing how the structure was represented in the matrix by increasing the 
initial height distance from the central atom (Height 1 and Height 2 included) 
There were multiple design constraints for this project. The first was the comparison with the 
BLOSUM matrices (30,62, and 90) which characterized the substitution ability of each pair of 
amino acids as found in nature. The next constraint was the use of the commonly found 
molecular signatures on the internet. This Honors project did not have funding in order to use the 
paid for and more accurate molecular signature descriptor method. The last constraint was the 
usage of the signature kernel equation which was used in order to repeat a previous study by 
Jean-Loup Faulon.   
The modified version of the molecular matrix improved the linear relationship R2 value from 
0.83 to 0.87. In Figure 7, the oscillation towards the middle of the graph indicates that the 
relationship is not very reliable. The modified matrix focuses on the side groups and therefore 
shows that it is not the only factor when finding similarity between two amino acids. 
The height 2 version of the molecular matrix improved the linear relationship R2 value from 0.83 
to 0.93. This linear relationship is even higher than the modified version of the signature kernel 
values. In Figure 8, the only “dip” was on the left end of the graph with the lower kernel values 
while the middle of the graph towards the right end showed an increased linear trend with 
consistent slopes across all BLOSUM matrices. Although, there is a consistent upwards slope 
towards the larger kernel signature values at the right end of the graph which shows an improved 
relationship in comparison to Figure 4. 
The modified matrix accounts for only the polarity and side groups which help explain why it is 
important to use an all-atom approach when finding similarities while using height 1. Height 2 
focuses on an all- atom approach and shows an even better relationship. The substitution ability 
is complex and relies on many factors besides pure structure. While in this investigation, polarity 
was proved to not be the only source, it is still an important factor when describing the amino 
acid quantifiably.  
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RECOMMENDATIONS:   
Due to a large improvement of the  linear correlation R2 value, it is apparent that height 2 was a 
better way to represent amino acid similarity. The height 1 matrix did not show the best linear 
relationship.  A height  greater than 2 could result with an even higher linear correlation value 
and could account for the three-dimensional connections of the amino acid. Further investigation 
should test different properties (size of amino acid and polarity) of heights greater than 2 in order 
to improve the molecular signature method.   
Future investigations should also account for  even higher heights and investigate different trends 
that mimic the trends found within the BLOSUM62 matrix. If further patterns are found within 
the BLOSUM62 matrix then it could be used to modify future signature kernel matrices and find 
even higher linear correlation than was found in this Honors Project. It is also recommended to 
keep in mind that multiple factors (different pH levels and intermolecular forces) occur at once 
and individual investigations may overlook the synergistic effect on the structure of the amino 
acid as seen in nature. 
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Appendix A 
C++ Code used to calculate the Signature Kernels  
#include <iostream> 
#include <fstream> 
#include <cstdlib> 
#include <cmath> 
#include <string> 
using namespace std; 
int main() 
{ 
    ifstream hc12; 
    ifstream hc11; 
    ofstream kernels("C:\\kernel.txt"); 
    double desmatrix1[21][34]; 
    double desmatrix2[21][34]; 
 
    int p, r, i, j, k, a, b, c, y, s; 
    double prod; 
    double prod1[21]; 
    double prod2; 
    double prod3; 
    double prod4; 
    double prod5; 
    double norm2[21][21]; 
    double norm1[21]; 
    double norm[21]; 
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    double kernel[21][21]; 
    double kernel1[21][21]; 
    double kernel2[21][21]; 
 
    hc12.open("HCdesmatrix.txt"); 
    hc11.open("HCdesmatrix1.txt"); 
 
    if(!hc12) 
    {cout << "File does not exist." << endl;} 
    if(!hc11) 
    {cout << "File does not exist." << endl;} 
 
    for (p=1; p <21; p++){ 
    for(r=1; r < 14; r++) 
    {hc12 >> desmatrix1[p][r];}} 
    for (p=1; p <21; p++){ 
    for(r=1; r < 34; r++) 
    {hc11 >> desmatrix2[p][r];}} 
 
    for (i=1; i <21; i++){ 
        prod = 0; 
         for (k=1; k <34; k++){ 
            hc12 >> desmatrix1[i][k]; 
            prod=prod+(desmatrix1[i][k]*desmatrix1[i][k]); 
            norm1[i] = prod; 
 
         for (s=1; s <21; s++){ 
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     prod5 =0; 
         for (y=1; y <34; y++){ 
            hc12 >> desmatrix1[i][y]; 
            hc12 >> desmatrix2[s][y]; 
            prod5 = prod5 + (desmatrix1[i][y]*desmatrix2[s][y]); 
            norm2[i][s] = prod5;} }} } 
    for (i=1; i <21; i++){ prod = 0; 
         for (j=1; j <34; j++){ 
               prod=prod+(desmatrix1[i][j]*desmatrix1[i][j]); 
               norm[i] = prod;}} 
     
         for (p=1; p <21; p++){ 
         for(r=1; r < 21; r++) 
    {hc12 >> desmatrix1[p][r]; 
        kernel1[p][r]= norm2[p][r] / sqrt((norm[p]*norm1[r])); 
cout << kernel1[p][r] << " " << p << " " << r <<  endl; 
kernels << kernel1[p][r] << " " << p << " " << r <<  endl;}}} 
return 0; } 
kernels – output matrix of the kernel data – to a datafile  
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Appendix B 
1. Amino Acid structures and their side groups. 
 
 
Figure 7. Each Amino Acid has a side group with different properties. Aspartate is Aspartic Acid 
and Glutamate is Glutamic Acid.  The amino acids shown were used in the investigation.5  
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2. Amino Acid 
Molecule Structure 
Alanine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O])- 
2.0 [H]([N])-- 
4.0 [H]([C])- 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
0.0 
Arginine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
2.0 [N]([C][H][H])-- 
1.0 [N]([C][C][H]) 
1.0 [N](=[C][H]) 
1.0 [H]([O])- 
6.0 [H]([N])-- 
7.0 [H]([C])- 
1.0 [C]([N][N]=[N]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][N]) 
1.0 [C]([C][C][H][N])-- 
2.0 [C]([C][C][H][H]) 
0.0  
Asparagine 
1.0 [O]([C][H])-- 
2.0 [O](=[C])-- 
2.0 [N]([C][H][H])-- 
1.0 [H]([O])- 
4.0 [H]([N])-- 
3.0 [H]([C])- 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][N]=[O]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
Aspartic Acid 
2.0 [O]([C][H])-- 
2.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
2.0 [H]([O]) 
2.0 [H]([N])-- 
3.0 [H]([C]) 
2.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
 
 
 
Cysteine 
1.0 [S]([C][H]) 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([S]) 
1.0 [H]([O]) 
2.0 [H]([N])-- 
3.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][S]) 
1.0 [C]([C][C][H][N])-- 
0.0  
Glutamic Acid 
2.0 [O]([C][H])-- 
2.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
2.0 [H]([O]) 
2.0 [H]([N])-- 
5.0 [H]([C]) 
2.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
2.0 [C]([C][C][H][H]) 
0.0 
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Glutamine 
1.0 [O]([C][H])-- 
2.0 [O](=[C])-- 
2.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
4.0 [H]([N])-- 
5.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][N]=[O]) 
1.0 [C]([C][C][H][N])-- 
2.0 [C]([C][C][H][H]) 
0.0 
 
Glycine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
2.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][N])-- 
0.0 
 
 
 
Histidine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N](p[C]p[C][H]) 
1.0 [N](p[C]p[C]) 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
3.0 [H]([N])-- 
5.0 [H]([C]) 
1.0 [C](p[C][H]p[N]) 
1.0 [C]([H]p[N]p[N]) 
1.0 [C]([C]p[C]p[N]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
 
 
 
 
 
 
 
 
 
 
Isoleucine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
10.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
2.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
1.0 [C]([C][C][C][H]) 
0.0  
Leucine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
10.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
2.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
1.0 [C]([C][C][C][H]) 
0.0  
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Lysine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
2.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
4.0 [H]([N])-- 
9.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][N]) 
1.0 [C]([C][C][H][N])-- 
3.0 [C]([C][C][H][H]) 
0.0  
Methionine 
1.0 [S]([C][C]) 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
8.0 [H]([C]) 
1.0 [C]([H][H][H][S]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][S]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
Phenylalanine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
8.0 [H]([C]) 
5.0 [C](p[C]p[C][H]) 
1.0 [C]([C]p[C]p[C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
Proline 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][C][H]) 
1.0 [H]([O]) 
1.0 [H]([N])-- 
7.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][N]) 
1.0 [C]([C][C][H][N])-- 
2.0 [C]([C][C][H][H]) 
0.0  
 
Serine 
2.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
2.0 [H]([O]) 
2.0 [H]([N])-- 
3.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][O]) 
1.0 [C]([C][C][H][N])-- 
0.0  
Threonine 
2.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
2.0 [H]([O]) 
2.0 [H]([N])-- 
5.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][O]) 
1.0 [C]([C][C][H][N])-- 
0.0  
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Tryptophan 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N](p[C]p[C][H]) 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
3.0 [H]([N])-- 
8.0 [H]([C]) 
1.0 [C](p[C]p[C]p[N]) 
1.0 [C](p[C]p[C]p[C]) 
4.0 [C](p[C]p[C][H]) 
1.0 [C](p[C][H]p[N]) 
1.0 [C]([C]p[C]p[C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
 
*NOTE* - The marked 
signatures are the common 
signatures that are 
removed or decreased to 
create the modified matrix. 
 
 
 
 
 
 
 
Tyrosine 
2.0 [O]([C][H])--1 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
2.0 [H]([O]) 
2.0 [H]([N])-- 
7.0 [H]([C]) 
1.0 [C](p[C]p[C][O]) 
4.0 [C](p[C]p[C][H]) 
1.0 [C]([C]p[C]p[C]) 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
0.0  
 
 
 
 
 
 
 
 
 
 
 
 
Valine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
8.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
2.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][C][H]) 
0.0  
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Appendix C 
Input Matrices – Both Original Molecular Signature and Shortened Molecular Signature 
 
Figure 8. The Matrix used for the Original Calculations. The Signatures describe the 
amino acids in alphabetical order as the second figure shows.
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Figure 9. The matrix used for the improved and modified version of the Molecular 
Signatures. The Signatures describe the amino acids in alphabetical order as the second 
figure shows. 
 
 
 
The modified matrix was created by finding six columns that were the same in each amino acid 
row. The modified columns were shown circled in Figure 9. The common number of similarities 
was found represented the backbone (carboxylic acid) of the amino acids. The common values 
were reduced or put as zero. The new matrix will focus more on the structure of the side chains 
and display polarity. 
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Appendix D 
Example calculation for the molecular signature kernel. 
 
Alanine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O])— 
2.0 [H]([N])-- 
4.0 [H]([C])- 
1.0 [C]([C][O]=[O])-- 
1.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
0.0 
 
σ(Aln) = (0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 
0, 0, 0, 0, 0, 0, 4, 2, 1, 0, 0, 0, 1, 0, 0, 1, 1, 0, 
0) 
|𝛔(𝐀𝐥𝐧)|𝟐 = (1+1+1+16+4+1+1+1+1) = 27 
 
|𝛔(𝐀𝐥𝐧)| =  √𝟐𝟕 
 
k(Aln, Leu) = 
𝝈(𝑨𝒍𝒏)∙ 𝝈(𝑳𝒆𝒖)
|𝛔(𝐀𝐥𝐧)| |𝛔(𝐋𝐞𝐮)| 
 = 0.92 
 
 
 
 
Leucine 
1.0 [O]([C][H])-- 
1.0 [O](=[C])-- 
1.0 [N]([C][H][H])-- 
1.0 [H]([O]) 
2.0 [H]([N])-- 
10.0 [H]([C]) 
1.0 [C]([C][O]=[O])-- 
2.0 [C]([C][H][H][H]) 
1.0 [C]([C][C][H][N])-- 
1.0 [C]([C][C][H][H]) 
1.0 [C]([C][C][C][H]) 
0.0  
σ(Leu) = (1, 1, 1, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 
0, 0, 0, 0, 0, 0, 10, 2, 1, 0, 0, 0, 1, 0, 0, 1, 1, 0, 
0) 
|𝛔(𝐋𝐞𝐮)|𝟐=(1+1+1+4+1+100+4+1+1+1+1)= 
116 
|𝛔(𝐋𝐞𝐮)| =  √𝟏𝟏𝟔 
 
 
